4.7 Letter

Assessment of rAAVrh.74.MHCK7.micro-dystrophin Gene Therapy Using Magnetic Resonance Imaging in Children With Duchenne Muscular Dystrophy

Journal

JAMA NETWORK OPEN
Volume 4, Issue 1, Pages -

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamanetworkopen.2020.31851

Keywords

-

Funding

  1. National Institutes of Arthritis and Musculoskeletal Disorders [R01AR056973, U54AR052646]
  2. National Institutes of Neurological Disorders and Stroke of the National Institutes of Health
  3. National Science Foundation [DMR-1644779, DMR-1157490]
  4. state of Florida

Ask authors/readers for more resources

This case-control study investigates the impact of treatment with recombinant adeno-associated virus serotype rh74 (rAAVrh74) on muscle quality in children with Duchenne muscular dystrophy using magnetic resonance imaging and spectroscopy techniques.
This case-control study uses magnetic resonance imaging and spectroscopy to evaluate the association between treatment with recombinant adeno-associated virus serotype rh74 (rAAVrh74) and muscle quality in children with Duchenne muscular dystrophy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available